GI Alliance, Texas Digestive Disease Consultants

Dallas, Texas 75246

0 studies enrolling now · 2 studies all time

What they study most

Cirrhosis, Liver, Metabolic Dysfunction-assocated Steatohepatitis/ Nonalcoholic Fatty Liver Disease, NASH

Studies at this site

• A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES) — Running, not enrolling
• Study of TVB-2640 in Subjects With Nonalcoholic Steatohepatitis (NASH) — Completed